Alert
Recommended Alerts
Can They Really Do That? The Specter of Government-Authorized Infringement of Pharmaceutical Patents
The perception that pharmaceuticals in the United States are overpriced, and that patent rights are why, has been a recurrent political theme over the last several years. This view, along with the ongoing novel coronavirus pandemic, has caused some to consider whether the U.S. government should act to ensure affordable access to potentially life-saving medicines.